busulfan 60mg10ml concentrate for solution for infusion vials
accord healthcare ltd - busulfan - solution for infusion - 6mg/1ml
busulfan 60mg10ml concentrate for solution for infusion vials
tillomed laboratories ltd - busulfan - solution for infusion - 6mg/1ml
busulfex® injection 60 mgvial
steward cross pte ltd - busulfan - injection, solution, concentrate - 60 mg/vial - busulfan 60 mg/vial
myleran 2 mg film-coated tablets
aspen pharma trading limited - busulfan - film-coated tablet - 2 milligram(s) - alkyl sulfonates; busulfan
busilvex
pierre fabre medicament - busulfan - hematopoietic stem cell transplantation - antineoplastic agents - busilvex followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busilvex following fludarabine (fb) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation (hpct) in adult patients who are candidates for a reduced-intensity conditioning (ric) regimen.busilvex followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.
busulfex solution
otsuka pharmaceutical co ltd - busulfan - solution - 60mg - busulfan 60mg - antineoplastic agents
myleran tablet
aspen pharmacare canada inc. - busulfan - tablet - 2mg - busulfan 2mg - antineoplastic agents
myleran
pharmacy retailing (nz) ltd t/a healthcare logistics - busulfan 2mg (milled) - film coated tablet - 2 mg - active: busulfan 2mg (milled) excipient: lactose magnesium stearate opadry white oy-s-7322 pregelatinised maize starch purified water
busilvex 60mg10ml concentrate for solution for infusion ampoules
pierre fabre ltd - busulfan - solution for infusion - 6mg/1ml
myleran 2 mg film-coat. tabl.
aspen pharma trading ltd. - busulfan 2 mg - film-coated tablet - 2 mg - busulfan 2 mg - busulfan